Effects of cigarette smoke exposure on clot dynamics and fibrin structure: An ex vivo investigation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 1, 2010, Pages 75-79

  Barua, Rajat S ^a   Sy, Fridolin ^a   Srikanth, Sundararajan ^a   Huang, Grace ^a   Javed, Usman ^a   Buhari, Cyrus ^a   Margosan, Dennis ^b   Ambrose, John A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b San Joaquin Valley Agricultural Sciences Center   (United States)

Author keywords

Fibrinogen; Platelet; Smoking; Thrombosis

Indexed keywords

ABCIXIMAB; CIGARETTE SMOKE; FIBRINOGEN;

ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EX VIVO STUDY; FIBRIN CLOT; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; THROMBOCYTE; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY; THROMBOGENICITY; TURBIDITY;

ADULT; BLOOD COAGULATION; BLOOD PLATELETS; FIBRIN; FIBRINOGEN; HUMANS; MALE; MICROSCOPY, ELECTRON, SCANNING; NEPHELOMETRY AND TURBIDIMETRY; RISK FACTORS; SMOKING; THROMBELASTOGRAPHY; THROMBOSIS;

EID: 73849087297     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.195024     Document Type: Article

References (21)

1. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43: 1731-1737.
2. Barua RS, Ambrose JA, Srivastava S, DeVoe MC, Eales-Reynolds LJ. Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide biosynthesis and upregulation of endothelial nitric oxide synthase: an in vitro demonstration in human coronary artery endothelial cells. Circulation. 2003;107:2342-2347.
3. Barua RS, Ambrose JA, Saha DC, Eales-Reynolds LJ. Smoking is associated with altered endothelial-derived fibrinolytic and antithrombotic factors: an in vitro demonstration. Circulation. 2002;106:905-908.
4. Greilich PE, Alving BM, O'Neill KL, Chang AS, Reid TJ. A modified thromboelastographic method for monitoring c7E3 Fab in heparinized patients. Anesth Analg. 1997;84:31-38.
5. Khurana S, Mattson JC, Westley S, O'Neill WW, Timmis GC, Safian RD. Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography. J Lab Clin Med. 1997;130: 401-411.
6. Craft RM, Chavez JJ, Bresee SJ, Wortham DC, Cohen E, Carroll RC. A novel modification of the Thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med. 2004;143:301-309.
7. Undas A, Szułdrzynski K, Stepien E, Zalewski J, Godlewski J, Tracz W, Pasowicz M, Zmudka K. Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress. Atherosclerosis. 2008;196:551-557.
8. Mills JD, Ariëns RA, Mansfield MW, Grant PJ. Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease. Circulation. 2002;106:1938-1942.
9. Carter AM, Cymbalista CM, Spector TD, Grant PJ. Heritability of clot formation, morphology, and lysis: the EuroCLOT study. Arterioscler Thomb Vasc Biol. 2007;27:2783-2789.
10. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ. Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol. 2005;46:937-954.
11. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995;91:2844-2850.
12. Rival J, Riddle JM, Stein PD. Effects of chronic smoking on platelet function. Thromb Res. 1987;45:75-85.
13. Fusegawa Y, Goto S, Handa S, Kawada T, Ando Y. Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. Thromb Res. 1999;93:271-278.
14. Blache D. Involvement of hydrogen and lipid peroxides in acute tobacco smoking-induced platelet hyperactivity. Am J Physiol. 1995;268: H679-H685.
15. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insight from the Framingham Study. Am Heart J. 1987;113:1006-1010.
16. Scott EM, Ariëns RA, Grant PJ. Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease. Arterioscler Thromb Vasc Biol. 2004;24:1558-1566.
17. Grant PJ. Diabetes mellitus as a prothrombotic condition. J Intern Med. 2007;262(2):157-172
18. Collet JP, Park D, Lesty C, Soria J, Soria C, Montalescot G, Weisel JW. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol. 2000;20:1354-1361.
19. Chernysh IN, Weisel JW. Dynamic imaging of fibrin network formation correlated with other measures of polymerization. Blood. 2008;111: 4854-4861.
20. Gersh KC, Nagaswami C, Weisel JW, Lord ST. The presence of gamma chain impairs fibrin polymerization. Thromb Res. 2009;124:356-363.
21. Kettner SC, Panzer OP, Kozek SA, Seibt FA, Stoiser B, Kofler J, Locker GJ, Zimpfer M. Use of abciximab-modified thromboelastography in patients undergoing cardiac surgery. Anesth Analg. 1999;89:580.